$1.71 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 24 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 41.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SPR | Buy | SPIRIT AEROSYSTEMS HLDGS INC | $222,640,000 | +6.7% | 2,707,197 | +5.6% | 13.03% | +40.6% |
| VST | Sell | VISTRA ENERGY CORP | $190,423,000 | -28.7% | 7,123,927 | -39.6% | 11.15% | -6.0% |
| JCI | Sell | JOHNSON CTLS INTL PLC | $154,373,000 | -6.8% | 3,517,264 | -12.3% | 9.04% | +22.8% |
| ITRI | Sell | ITRON INC | $142,043,000 | -30.4% | 1,920,540 | -41.1% | 8.31% | -8.2% |
| BABA | New | ALIBABA GROUP HLDG LTDsponsored ads | $133,565,000 | – | 798,691 | +100.0% | 7.82% | – |
| VG | Buy | VONAGE HLDGS CORP | $132,135,000 | +33.1% | 11,693,319 | +33.5% | 7.73% | +75.4% |
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $114,954,000 | +11.4% | 4,221,585 | -1.6% | 6.73% | +46.9% |
| NXPI | Buy | NXP SEMICONDUCTORS N V | $113,517,000 | +30.0% | 1,040,298 | +16.3% | 6.64% | +71.4% |
| WBT | Buy | WELBILT INC | $110,595,000 | +14.9% | 6,559,589 | +13.8% | 6.47% | +51.4% |
| ZGNX | Buy | ZOGENIX INC | $63,986,000 | -6.0% | 1,598,051 | +12.2% | 3.74% | +23.9% |
| BA | New | BOEING COput | $58,973,000 | – | 155,000 | +100.0% | 3.45% | – |
| UPWK | New | UPWORK INC | $58,290,000 | – | 4,381,052 | +100.0% | 3.41% | – |
| HHR | Sell | HEADHUNTER GROUP PLCsponsored ads | $40,897,000 | +15.1% | 2,120,110 | -3.0% | 2.39% | +51.7% |
| RTRX | Sell | RETROPHIN INC | $37,319,000 | -52.2% | 3,219,898 | -17.1% | 2.18% | -37.0% |
| HLIT | Sell | HARMONIC INC | $33,753,000 | -0.2% | 5,129,642 | -15.8% | 1.98% | +31.6% |
| PTCT | Sell | PTC THERAPEUTICS INC | $29,484,000 | -33.3% | 871,780 | -11.3% | 1.73% | -12.2% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $27,065,000 | -84.7% | 91,200 | -84.9% | 1.58% | -79.9% |
| WMGI | New | WRIGHT MED GROUP N V | $19,234,000 | – | 932,333 | +100.0% | 1.13% | – |
| ACOR | Sell | ACORDA THERAPEUTICS INC | $7,961,000 | -68.8% | 2,773,777 | -16.5% | 0.47% | -58.8% |
| PSEC | New | PROSPECT CAPITAL CORPORATION | $7,152,000 | – | 1,085,322 | +100.0% | 0.42% | – |
| FOSL | FOSSIL GROUP INC | $4,953,000 | +8.8% | 395,925 | 0.0% | 0.29% | +43.6% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $3,769,000 | -16.6% | 56,794 | 0.0% | 0.22% | +10.0% | |
| MNKD | MANNKIND CORP | $1,167,000 | +8.7% | 933,612 | 0.0% | 0.07% | +41.7% | |
| AMSC | AMERICAN SUPERCONDUCTOR CORP | $154,000 | -15.4% | 19,610 | 0.0% | 0.01% | +12.5% | |
| KAR | Exit | KAR AUCTION SVCS INC | $0 | – | -2,565,615 | -100.0% | -2.85% | – |
| IAA | Exit | IAA INC | $0 | – | -2,318,366 | -100.0% | -3.99% | – |
| SRC | Exit | SPIRIT RLTY CAP INC NEW | $0 | – | -2,695,324 | -100.0% | -5.11% | – |
| ETRN | Exit | EQUITRANS MIDSTREAM CORPORAT | $0 | – | -6,783,588 | -100.0% | -5.94% | – |
| IWM | Exit | ISHARES TRput | $0 | – | -932,700 | -100.0% | -6.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
| SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
| ISHARES TR | 28 | Q3 2023 | 10.9% |
| MANNKIND CORP | 24 | Q3 2023 | 0.5% |
| BAIDU INC | 21 | Q2 2018 | 8.6% |
| ITRON INC | 21 | Q3 2020 | 12.1% |
| RETROPHIN INC | 20 | Q3 2020 | 4.5% |
| HARMONIC INC | 19 | Q3 2023 | 10.5% |
| JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
| ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
| Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
| Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
| Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
| ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
| ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
| ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
| LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
| Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
| GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D | 2024-04-26 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13D/A | 2024-01-22 |
| 13F-HR/A | 2023-11-14 |
| 13F-HR | 2023-11-14 |
| SC 13D | 2023-09-21 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.